In fact, blocking Bcl-XL expression in prostate cancer cells decreased cell proliferation [28,29] and silencing the AR gene in prostate cancer cells significantly reduced Bcl-XL expression and increased apoptosis [30]. Here, BCL2L1 is linked to prostate carcinoma.